Cardio Diagnostics Holdings, Inc

CDIONASDAQ · In Vitro & in Vivo Diagnostic Substances

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

2.96M

on 2026-06-30, from 61K on 2025-12-31 10-Q ↗

Earlier counts are adjusted for the 1-for-30 reverse split; each bar's tip shows the count as filed.

Counts before 2025-12-31 are left out: the count went from 1.77M on 2025-09-30 to 61K on 2025-12-31, a change no split on file explains.

Newest

$50.0M

S-3 of 2025-02-07. 1 prospectus supplement filed under it since. S-3 ↗

$9.5M

Craig-Hallum Capital Group, agreement of 2025-02-14. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-07 is not read yet.

Cash

under 0.1 quarters

$0 on 2026-06-30 ÷ $1.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 1 of its filings are not read yet.

Also on file: a 1-for-5 reverse split, 2025-05-12 8-K ↗